Sign in
  Edit search
Cost-effectiveness of new guidelines for adjuvant systemic t…
Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer.
Cost-effectiveness of new guidelines for adjuvant systemic therapy for patients with primary breast cancer.
Article, Chapter
Authors: W. Kievit
Publication: Annals of Oncology, Volume:16, Issue:12, Page(s):1874-1881
Published: Elsevier, 2005
ISSN: 0923-7534
  Full text availability for this item
View Full Text Source:Annals of Oncology,Annals of Oncology,Elsevier ScienceDirect Journals Opens in new Window
Journal:  Annals of Oncology Source:Elsevier ScienceDirect Journals Opens in new Window
Collection:  Elsevier ScienceDirect Journals Opens in new Window
Coverage:
  • 1990~present
View Full Text Source:Annals of Oncology,Annals of Oncology,PubMed Central Opens in new Window
Journal:  Annals of Oncology Source:PubMed Central Opens in new Window
Collection:  PubMed Central Opens in new Window
Coverage:
  • 1990~12 months ago
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item